Thailand's dust-mite allergy vaccine first in South-east Asia

BANGKOK (The Nation/ANN): Mahidol University (MU) is developing versions of its new dust allergy vaccine that patients will be able to use at home, reducing their risk of being exposed to Covid-19.

MU’s Faculty of Medicine Siriraj Hospital earlier announced it had successfully developed South-east Asia’s first dust allergy vaccine, which has been registered with the Food and Drug Administration (FDA) and is protecting patients who are allergic to dust mites.